PFIZER INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
Mailing Address 66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
Phone 2127332323
Fiscal Year End 1231
EIN 135315170
Financial Overview
FY2024
$31.37B
Net Income
$226.50B
Total Assets
$2.85B
Cash & Equivalents
$5.59
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13D/A Beneficial ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 13F-HR Institutional investment holdings | February 12, 2026 | View on SEC |
| 8-K Current report of material events | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 16, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
Material Events
8-K Strategy Change December 16, 2025
High Impact
- Pfizer updated its financial outlook, narrowing 2025 revenue guidance to approximately $62.0 billion while reaffirming 2025 Adjusted Diluted EPS guidance.
- New 2026 forecasts project revenues of $59.5 billion to $62.5 billion and Adjusted Diluted EPS of $2.80 to $3.00.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.